2023-03-10 17:31:23 ET
- Amid concerns about smaller pharma and biotech companies' exposure to Silicon Valley Bank ( SIVB ), a number of them have disclosed that they have no relationship with the FDIC-shuttered financial institution .
- Among the larger ones are Cara Therapeutics ( NASDAQ: CARA ), Iovance Therapeutics ( NASDAQ: IOVA ), and Karyopharm Therapeutics ( NASDAQ: KPTI ).
- Others are: Allogene Therapeutics ( ALLO ), Avid Bioservices ( NASDAQ: CDMO ), Macrogenics ( MGNX ), Precision BioSciences ( DTIL ), ProQR Theraopeutics ( PRQR ), Maravai LifeSciences ( MRVI ), RVL Pharmaceuticals ( RVLP ), ANI Pharmaceuticals ( ANIP ), G1 Therspeutics ( GTHX ), and Vapotherm ( VAPO ).
For further details see:
Cara, Iovance, and Karyopharm among biotechs with no exposure to SVB